Myoid gonadal stromal tumours are characterised by recurrent chromosome‐level copy number gains: molecular assessment of a multi‐institutional series.

MLA

Collins, Katrina, et al. “Myoid Gonadal Stromal Tumours Are Characterised by Recurrent Chromosome‐level Copy Number Gains: Molecular Assessment of a Multi‐institutional Series.” Histopathology, vol. 82, no. 3, Feb. 2023, pp. 431–38. EBSCOhost, https://doi.org/10.1111/his.14825.

APA

Collins, K., Sholl, L. M., Siegmund, S., Dickson, B. C., Colecchia, M., Michalová, K., Hwang, M., Ulbright, T. M., Kao, C., van Leenders, G. J. L. H., Mehta, V., Trpkov, K., Yilmaz, A., Cimadamore, A., Matoso, A., Epstein, J. I., Maclean, F., Comperat, E., Anderson, W. J., & Fletcher, C. D. M. (2023). Myoid gonadal stromal tumours are characterised by recurrent chromosome‐level copy number gains: molecular assessment of a multi‐institutional series. Histopathology, 82(3), 431–438. https://doi.org/10.1111/his.14825

Chicago

Collins, Katrina, Lynette M. Sholl, Stephanie Siegmund, Brendan C. Dickson, Maurizio Colecchia, Květoslava Michalová, Michael Hwang, et al. 2023. “Myoid Gonadal Stromal Tumours Are Characterised by Recurrent Chromosome‐level Copy Number Gains: Molecular Assessment of a Multi‐institutional Series.” Histopathology 82 (3): 431–38. doi:10.1111/his.14825.